News 14/04/2021

Deenova Wins First Private Contract in Spain for Hospital Centro de Andalucía de Lucena

MILAN–(BUSINESS WIRE)–Deenova announced today that its unrivalled market momentum unceasingly expands to Spain´s private hospital market, with its first award for won by Deenova in cooperation with Algalasa at Hospital Centro de Andalucía at Lucena, Cordoba, part of the new health enterprise Amaveca Salud.

Gaspar G. De Viedma, Vice Chairman of the Deenova Board of Directors stated:

“I am happy to see the first results of the Deenova´s cooperation with our partnership with Algalasa in such a short period of time, and together with our prior award at Bellvitge University Hospital in Barcelona to demonstrate once again Deenova´s unique scalability in hospitals ranging from 100 to 2.000 beds, with the installation of the ACCED and ASTUS mechatronic medication solutions in 2022.”

Jose Luis Temes, M.D., Algalasa’s President and former Sub-secretary of Health at Spain Ministry of Health, Director of National Health Service in Spain, and Managing Director of multiple Spanish hospitals, including Foundation Jimenez Diaz, Hospital La Paz, and Hospital Queen Sofia, added: “This milestone was possible thanks to the hospital owners understanding of the importance of closing the loop of the medication, from prescription to patient administration, and the unique Deenova’s technology. Centro de Andalucía in Lucena will be a reference in patient safety, staff satisfaction, quality and efficiency of pharmacy processes.”

Hospital Centro de Andalucía de Lucena is located in the Andalucian city of Lucena in Cordoba. With 350 employees serving up to 200 beds, including surgery, a diagnostic area, analysis, a day hospital and physiotherapy, among other services. Its innovative new construction has been equipped with all kinds of details, such as domotic rooms, and patient entertainment systems (tablets, televisions, etc).

Deenova is the undisputed leading supplier of mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere.

Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.

Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

 

News 18/03/2021

Deenova Wins Tender at San Camillo Hospital expanding its European Win Streak to Italy

MILAN–(BUSINESS WIRE)–Deenova today publicly disclosed that its unprecedented market success in 2020 relentlessly expanded to Italy in 2021, with the recent Public Tender Award won at San Camillo Forlanini Hospital for multiple unit-dose robots, electronic prescription, automated medical devices traceability, and a full service model for the utilisation of Deenova’s world-class solutions.

Giorgio Pavesi, Managing Director of Deenova in Italy stated: “It is a testament to Deenova European market momentum started in 2020 to combine new business robot and service contracts at premier hospitals in Europe, with additional purchase of technologies and complex services by previous Deenova customers, clearly showing a high level of continued satisfaction with our automation solutions amongst our existing customer base, such as San Camillo Forlanini Hospital.”

San Camillo – Forlanini Hospital is a major public health institution located in Rome with 730 patient beds and is included in the regional health system as a HUB center. Patient Care Departments and Administration offices are distributed over 14 pavilions, covering a total area of 238,000 m².

Since 2004, Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 13/01/2021

Patient Care Crafted for Better Safety and Greater Therapy Compliance

CIO APPLICATIONS EUROPE — In the healthcare sector, the ‘applicability of technology’ carries far greater importance than the technology itself. Technology today is more so about than finding the right equilibrium of cost, applicability, and benefits. Such an equilibrium would eliminate human errors and increase treatment compliance, effectively leading to better quality of care for patients, while enhancing the productivity of healthcare professionals. Deenova—a supplier of robotics and automation solutions for closed-loop medications and medical devices traceability—has achieved this equilibrium through its mechatronics proficiency. From prescription to administration to bed side verification, Deenova’s technological solutions are designed to be cost-effective, intuitive, and sensitive. The company’s All-in-one repackaging robot creates unit dose, repacks and labels all pharmaceutical formats: oral solid and liquid medications, such as vials, syringes, ampoules, and all other formats of patches sachet, and suppositories. These unit doses are then loaded on to the company’s All-in-one station, located discretely at various patient care departments across hospitals and pharmacies. Alongside these solutions, Deenova also offers Orbit – a proprietary software for e-prescribing and micro logistics management, capable of automatically generating a reordering list of unit doses based on doctor recommendations in realtime. The system caters to the fully automated therapy preparations and dispensation through the Deenova All-in-one Station, which loads the specific unit doses on to the All-in-one Trolley. This comprehensive system empowers nurses to initiate therapy administration with the All-in-one Trolly, thereby ensuring that the right therapy is given to the right patient by scanning the patient’s identification tag. Conclusively, Orbit orchestrates a decentralized model for patient care, wherein, the unit doses are produced centrally while the patient-specific therapies are prepared in the corresponding care departments.

“We do not position ourselves as a Technology Vendor, but rather provision a unique business model, in which, we partner with healthcare facilities and guarantee Full service 24/7 thanks to the combination of proprietary hardware, software and people,” explains Christophe Jaffuel, the chief commercial officer of the company. Deenova’s Orbit software combines e-prescribing and micro logistics, showcasing the ability the interoperate alongside 50 other solutions. Jaffuel terms this applicability as a ‘string advantage for customers’ that require cross-platform solutions.
Comprehending these string of benefits, it is safe to say that Deenova has created a reliable and efficient patient care ecosystem with multiple use cases. For instance, healthcare facilities seeking to improve medication management can reduce the cost of administering medications in their facilities while minimizing error and increasing patientnurse engagements. This merit alone translates to higher productivity among nurses and lower financial overheads involved in medication management– an expenditure that is skyrocketing in the current day and age. More importantly, Deenova reduces inventory management, eliminates duplication, ensures traceability of medication, provisions governance and control over clinical and logistics processes.
These value propositions are driven by Deenova’s people and the patient-centric vision that the company upholds through its mechatronics portfolio of products, designed to overhaul medication traceability. The company has recently introduced these functions into the retail pharmacy sector as well, facilitating home delivery of medications. “It is not difficult to picture a world where the patients needing medication could benefit from online prescriptions, telemedicine and e-pharmacy, while receiving personalized therapies at the comfort of their homes, in the right quantity, for the exact duration of the treatment, with necessary support,” adds Jaffuel. Without a hint of doubt, Deenova has materialized this world, all the while increasing safety and therapy compliance.

Read the full magazine Cio Applications Europe

 

 

News 12/01/2021

Deenova Wins Top 10 Robotics Award, and AP-HP and Francois Quesnay Public Tenders

MILAN–(BUSINESS WIRE)–Deenova separately announced today three key awards won by our innovative mechatronic service solutions company, the 2020 Top 10 Robotics Solutions by CIO Applications Europe and Deenova winning its entry through its latest Resah public tender win for its D3 ACCED Robot to be operated 24/7 at prestigious AP-HP (l’Assistance Publique-Hôpitaux de Paris) in Hendaye and François Quesnay Hospital Center for 2 of the company D3 ASTUS solutions.

Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “We finished 2020 and started 2021 with a bang, I am very proud of our team latest unparalleled accomplishments in our industry. These 2 latest company wins highlight Deenova main differentiating characteristics, patient care crafted for better safety and greater therapy compliance, and 24/7 availability, a key component of AP-HP needs”.

AP-HP (l’Assistance Publique-Hôpitaux de Paris) is a globally recognized university hospital center with a European dimension. Its 39 hospitals welcome more than 10 million patients per year: consultations, emergencies, hospitalizations and finally home care, at all ages of life, providing public health service for all, 24/7.

François Quesnay Hospital Center is a 612-bed hospital in the Paris metropolitan area, with a budget of 125 million euros and 175 doctors.

CIO Applications Europe magazine stands out with its unique approach of learning from peers approach offering professionals the most comprehensive collection of technology trends, being the single most successful initiative Pan-Europe.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 08/01/2021

San Martino Hospital in Genoa is among the winners of ‘Lean Health Award 2020’, thanks to Deenova solutions

‘Lean Healthcare and Lifescience Award’ rewards the best healthcare reorganization projects in Italy. San Martino Hospital was among the winners for the best project in the field of ‘Business risk management’.


San Martino Hospital was awarded as best project in ‘Business risks management’ at ‘Lean Healthcare and Lifescience Award 2020’. The event, organized by Telos Management Consulting in collaboration with Federsanità, Aiop, Fiaso and University of Siena, rewards the best health reorganization projects in Italy.

The project, which is part of San Martino Hospital strategy  in investing in medications computerized management, is called ‘Direct-Sofia‘ and is the revision of direct distribution of medication to Hospital patients (direct distribution is meant as medications dispensing, through healthcare facilities, to the out-patients, for home administration) with the purpose of increasing safety in therapy distribution, thanks to the concomitant adoption of a new application as unique tool to manage prescription phase and medications distribution to patients.

The systematic presence of a computerized medical prescription in the first phase of medications distribution will allow to enhance traceability along the entire path, through the identification of barcode on medication boxes and to verify timely correspondence to prescription and to patient’s registry. All the information recorded gave, at the same time, the possibility to hospital pharmacist to conduct useful analyzes on patient’s compliance with therapeutic plan and, consequently, on therapy effectiveness.

Click here to review the presentation of the ‘Direct-Sofia’ project of San Martino Polyclinic Hospital.

https://www.ospedalesanmartino.it/

News 16/12/2020

Deenova Accomplishes the Design, Re-Branding, and Virtual Tour of its World Class Solutions

MILAN–(BUSINESS WIRE)–Deenova announced today the completion of company re-branding and the re-design its website in five languages, especially developed for Covid-19 times, including Virtual Tour and Self-Configuration tools for its world class solutions, coinciding with the company’s unprecedented international success in 2020.

Gaspar G. De Viedma, Vice Chairman of Deenova Board of Directors stated: “Deenova sales and marketing team has just established a new industry standard for how Pharmacy Automation solutions are introduced to the medical industry, automatically configured in Deenova´s web site, and tied to specific evidence based benefits and R.O.I. Over my 35 years of health care and technology industry experience, I have never witnessed anything that comes even close to Deenova´s launch, once more demonstrating why it holds its market leading position.”

Deenova D1 Series error-free mechatronics technology is the first and only fully automated closed loop solution for the management of both medication and medical supplies, ensuring total traceability from prescription to bed side verification. Including the All-in-1 robot, All-in-1 Station dispensing unit, All-in-1 Trolley with secure bed-side verification, and finally Orbit E-Prescribing and micrologistic management software.

Deenova D3 Series for the automatic repackaging and dispensation of personalized therapies in unit doses include Acced, a completely autonomous robot potentially used 24/7, that prepares the unit doses from previously loaded medication blisters, and Astus, installed directly in the patient care departments for controlled storage and administration of all types of medication therapies.

Deenova D8 Series, complementary to Deenova D1 Series, managing hospital micrologistics and full traceability of medical supplies include: Orbit, CheckIn, Sentinel, Sentry, and Frontier.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimize waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 02/12/2020

Deenova Bolsters its 2020 Market Momentum in Pharmacy Automation with entry into Poland

MILAN–(BUSINESS WIRE)–Deenova announced today that in continuing its meteoric 2020 business boom, it made its first foray into Eastern Europe with new contracts for delivery of its market leading pharmacy robots and related technologies to Greater Poland Children’s Health Centre in Poznań, with Polish leading equipment company MEDIM in Piaseczno. 

 Piotr Młynarczyk, MEDIM General Manager, stated: “After a long search on a competitive sales process that throughly searched all options for pharmacy unit dose robots, I am very proud to select Deenova for partnership in the project at Greater Poland Children’s Health Centre in Poznań.We chose Deenova solutions, mainly because of their unique technology and business approach to R.O.I.” 

 Christophe Jaffuel, Deenova Chief Commercial Officer, added: “I am extremely excited to have been selected by Greater Poland Children’s Health Centre in Poznań, and Poland medical technology leader MEDIM, especially after their extensive experience comparing and contrasting Deenova´s solutions to those of our competitors. 

 Greater Poland Children’s Health Centre in Poznań is a state of the art 354 new paediatric hospital, one of the largest children hospitals in Poland, opening its doors to patients in 2021, with 9 units and a dozen specialist clinics. 

 MEDIM is a dynamically developing company with 30 years of experience. The company was founded in 1990 and since the beginning of its activity has focused on comprehensive and fully professional service of health care units in the field of innovative and effective medical technologies. Currently, the company is one of the top medical equipment distributors in Poland, employing 80 expert staff. 

 Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenovas unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providersgrowing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 18/11/2020

With APHM, Deenova Smashes All-Time Record in France Pharmacy Automation Market

MILAN–(BUSINESS WIRE)–Deenova today announced that its unsurpassed pharmacy automation market success in 2020 continues unabatedly this trimester, with new business contracts won by Deenova for multiple robots and multiyear service contracts at public tenders awarded by Resah, Achat Hopital and Assistance Publique–Hôpitaux de Marseille Centre Hospitalier Conception, and Centre Hospitalier de Tourcoing.

Loïc Bessin, Managing Director of Deenova in France stated: “It is a testament to Deenova unprecedented market momentum in 2020 to already reach our best all-time performance, even if these difficult Covid-19 times, with new business robot contracts at premier university hospitals such as APHM. 2020 is by no means over yet, and it has already been the best year in the history of Deenova France.”

APHM (Marseille Public University Health System) is the third largest hospital in France and the largest health centre in the Provence–Alpes–Côte d’Azur region, offering the highest standards of clinical skills and nursing care, with 4 hospitals, 3.400 beds, 1.25 billion euros budget, 81 operating rooms, and 2,000 physicians.

Centre Hospitalier de Tourcoing is a regional hospital with 975 beds, near the Belgian border, and a group member of the GHT Lille Métropole Flandre Intérieure. It serves an area of 230 municipalities, with a population of 1.5 million inhabitants.

Resah is a public interest group (GIP) whose objective is to support the pooling and professionalisation of purchases from the health sector, public and private non-profit, through its public procurement platform Achat Hopital.

Christophe Jaffuel, Deenova Chief Sales Officer, added: “I am extremely pleased to continue to see the excellent progress that the sales team is making in France this year, clearly surpassing Deenova´s 2020 expectations and breaking all-time company records in France, even with the inherent difficulties and challenges that the Covid-19 tragedy poses in my beloved country right now.”

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 05/11/2020

Deenova Cracks its First Pharmacy Automation Market Outside Europe: Middle East

MILAN–(BUSINESS WIRE)–Deenova reported today that for the first time, it burst in business outside Europe with a significant win through its exclusive distribution contract with leading GCC pharmacy automation PharmaTech Medical Equipment. 

 Nabeel Al Aswad, General Manager of PharmaTech stated: “Over the years since PharmaTech has been established, our goal was to provide the patients and healthcare professionals with the right tools to improve patient safety, convenience, and efficiency. The addition of Deenova solutions to our portfolio gives pharmacy and hospital customers in the Middle East access to the world leading pharmacy technology including the most versatile Full Automated packaging Robot, All-in-One Station, and state-of-the-art RFID solutions, to further increase patient safety and efficiency. Particularly impressive to me and my 25 years experience working as a clinician in GCC hospitals, and as an employe of multinational American companies is Deenova service model approach to contracts, after witnessing first hand that purchasing Automated Dispensing Cabinets for Pharmacy Automation like Baxter, Becton Dickinson-CarefusionRowa, Omnicell-Health Robotics and other well known American and European and Asian brands has been a huge challenge to the decision makers in both private and public hospitals.” 

 Christophe Jaffuel, Deenova Chief Commercial Officer, added: “I am extremely pleased to have been selected by GCC pharmacy automation leader PharmaTech, especially after their extensive prior experience distributing Becton Dickinson-CarefusionRowa, Omnicell products to an already strong Deenova sales team. They chose Deenova over other competitors solutions because of its unique technology and business approach to R.O.I., and well proven total service solutions. 

 Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenovas unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 16/09/2020

Health 4.0 – Il Sole 24 Ore DOSSIER

Il Sole 24 Ore, the Italian national daily business newspaper, highlights how a fully automated management of medications and medical devices improves quality of care, patient safety and efficiency within healthcare institutions.
Politecnico of Milano, Pavia Asst and San Martino University Hospital of Genoa shared their success stories in implementing Deenova’s mechatronics solutions.

Read the Original Dossier

Il Sole 24 Ore – 16 Sep. 2020 by Natascia Ronchetti

Health 4.0 – Managing hospitals and local health units through machines and digitalisation by monitoring processes, from production to drug administration. The result? Fewer costs and more efficiency

Medicine 4.0 to cut down on costs and make the whole system more efficient

Telemedicine, electronic health records, conversion of drugs to single dosage forms, not only by leveraging computerisation and automation, but tracking medical and hospital devices as well. The roadmap for the digitalisation of the health system is open; the Covid-19 pandemic has indeed sped up the transition.

During the health emergency, many Regions gave the go-ahead to the provision of services such as teleconsultations. While the number of doctors who customarily use telemedicine, one of the new accomplishments of health 4.0, has doubled – bouncing from 5 to 10%. An unavoidable route but still full of obstacles. «The government has indeed included it among its priorities – said Chiara Sgarbossa, Head of Digital Innovation in Healthcare Observatory of Politecnico di Milano -. But we are still far from a real model of connected care; namely, a connected accuracy-based national system, geared towards the territory and care continuity, and that is capable of immediately providing all information on a patient, about their clinical history and health condition. The situation is still very piecemeal. And not all medical centres have yet enabled the electronic health record, for example».

The differences do not concern so much the North or the South of the country, but the single local health units: « Each one moves on its way, unevenly, even within the same region», Sgarbossa continued. The result is that there are only 18 million electronic health records: not even half the population has been reached. The Covid era has raised awareness of the strategic value of digitalisation to minimise waste and clinical risk. It has also brought about a cultural turning point in the world of family practitioners. According to a recent research project conducted by the Digital Innovation Observatory of the Polytechnic University of Milan, around 62% would currently like to use telemedicine and communicating with patients through platforms such as Skype or Zoom is indeed on the rise. «This said, investments are needed to achieve goals – Sgarbossa continued -. And the goal is offering a multitude of access channels to health services, with simple solutions at everyone’s fingertips».

The most critical period of the epidemic – during which over 50% of general practitioners worked remotely – confirmed the importance of new technologies also as regards access to information by citizens: 56% visited institutional web pages, 28% physicians’ and politicians’ social media, 12% coronavirus-related apps. « The fact remains that many hospitals are still at an early stage, and the journey is very long», – said Giorgio Pavesi, president and administrator of Deenova, a mechatronics company based in Gragnano Trebbiense, in the province of Piacenza, which develops automated systems for computerised management of drugs and medical devices. Deenova serves 25 hospitals, including university polyclinics and small provincial centres. The majority are concentrated in the North of the country, but there are also examples such as Rome-based Gemelli University Hospital, which is now able to track down 100% of medical devices, from the supply process to the operating room. Excellencies still disconnected. «Even if integration projects with already available IT systems are increasing – Pavesi explained -. After all, we are talking about an innovation pervading all specialist areas». Meaningful examples can be found abroad too. A study by the English University of Loughborough documented that the consumption of medicines decreased of 25% in the hospital of Leicester – where Deenova implemented a computerised prescription order entry system for drugs in four wards, by automatically preparing personalised treatments in unit doses. Now the project will be extended to the whole hospital.

However, there are already very advanced regions in Italy. Such is the case of Emilia-Romagna, where the electronic health record is already a reality for 89% of the population. To have some comparison parameters, suffice it to say that the involved citizens in Lombardy are 56% and in Tuscany 57%. «An element that proved crucial during the emergency – said Emilia Romagna’s health regional councillor Raffaele Donini – and that has become part of our health system as a structural component. For us, it is a core element of the system’s innovation. We can indeed state that we have taken a leap forward of extraordinary importance towards simplification and citizens’ health safety».

A single telemedicine software platform has now also been enabled here, with a set of services, from taking charge of chronic patients, through to managing them.

The waste of medicines decreased by more than 50 per cent in the Pavese area

First of all, the appropriateness of treatments significantly improved by reducing their risk margins: an installed system immediately alerts healthcare staff if they are administering a wrong drug, or if a patient is taking a given medicine at a different time than prescribed by the doctor. In addition, medicine stocks were reduced by 50% and expiring stocks removed, thus achieving a 7% reduction in wasted drugs. They also realised that 10% of nurses’ working time had been recovered – the time they used to spend preparing medicaments. All this as a result of computerisation and automation.

«A significant advantage even in the most challenging months of the Covid-19 epidemic – said Michele Brait -. We managed to continuously monitor the effectiveness of treatments and vital parameters of the patients, whereas, thanks to a very useful resource such as telemedicine, not severely ill patients could be assisted at their homes». Brait is the general manager of Pavia Local Healthcare Area (Asst),  a catchment area including 640 thousand people, located between the Pavia area and a part of Piedmont and Liguria. The Local Healthcare Area includes seven hospitals, the largest being those based in Vigevano and Voghera. In all, 43 wards – for a total staff of 1,500 doctors, nurses, pharmacists, social and health workers – where computerised management of drugs, from prescription to administration, was introduced in 2012. A project, commissioned by the Lombardy Region, jointly developed with Deenova, the Piacenza-based company specialised in developing automated systems for the management of medicines and medical devices.

In a small hospital in Mede, a town with about 6 thousand inhabitants, eight beds equipped with non-invasive sensors – some applied to the beds, others to patients – were also made available to measure body temperature, heart rate and quality of sleep. These sensors also alert nurses if the patient’s position needs to be changed, or if the patient tries to get out of bed at the risk of falling. «And now we are thinking of bringing the sensors into patients’ homes, or nursing homes – explains Brait – This way, doctors can keep everything under control remotely and hospitalise patients only when required. We are also testing with a bracelet which provides all vital signs as an intensive care monitor. In our opinion, the real challenge of health 4.0 is not so much linked to monitoring an acute phase, but rather to consistently monitoring the patient».

Drugs traceability is currently ensured in all the hospitals included in the Pavia Local Healthcare Area (Asst). Drug prescription is computerised, as are the cabinets automatically loading ward trolleys with single doses, to eliminate wasted drugs, while patients are equipped with electronic bracelets that make it possible for a nurse or doctor to always check patients’ identities, resulting in more appropriate treatments. «This way we could track down over 2.3 million administrations, including IV drip infusions and tablets» Brait continued – and we computerised operating theatres as well, by tracking down implantable medical devices».

Anti-Covid single doses at San Martino Hospital in Genoa

During the most challenging phase of the Covid-19 pandemic health emergency, being able to repackage drugs in unit doses was a real innovation and one of the weapons some hospitals took advantage of to guarantee access to treatments for the sick. Even hydroxychloroquine-based drugs (Plaquenil, manufactured by French multinational Sanofi), used against rheumatic diseases for decades, and then against the coronavirus as well, until the suspension decided by the Italian drug agency.

Technically, the conversion into single doses is called singling. And it is precisely through this method that hospitals such as the San Martino University Polyclinic in Genoa also managed to supply pharmacies throughout the Liguria region, bypassing the obstacle posed by this drug being scarcely available on the market. «We singled almost 45 thousand tablets in a week, thus supporting local communities», said Sabrina Beltramini, director of San Martino hospital’s pharmacy, which employs 60 people among pharmacists, nurses, technicians and warehouse workers. All thanks to automation and computerisation, jointly with Emilian company Deenova. «We have devised a whole singling plan aimed at preparing unit doses in sachets with bar codes for full traceability», Beltramini continued. As a matter of fact, a hydroxychloroquine pack contains thirty tablets, but the standard treatment initially envisaged by doctors called for just sixteen being administered. Thus, repackaging made it possible to avoid wasting drugs and to supply 590 pharmacies based in the Liguria region, as opposed to Sanofi’s difficulty in meeting the quick, massive increase in demand. A decision made by the Region, which secured a supply, and then commissioned the polyclinic to prepare the tablets in single doses, and send them to each Regional drug centre, in charge of distribution. «This way, we could also reach patients at home, while also managing to maintain the whole hospital production in place: a great effort that involved all staff», Beltramini explained.

An effort that also involved antiretroviral medicine – generally used for people with HIV, but also as an alternative for Covid patients – in many hospitals. San Martino Hospital in Genoa has 1,300 beds. Thirteen years have gone by since the computerisation operation for medicine management has kicked off. Here too, as a matter of fact, the path has been traced, from doctor prescription to nurse administration, with 26 automated cabinets dispensing medicines in unit doses. At any time, healthcare staff can know for each patient which treatment was selected, when it was prescribed and when it was administered: through the system 6,000 single doses can be daily packaged and tracked down. A solution that has also proved useful in better managing the use of antibiotics and reducing clinical risk: the latest internal study showed that it fell from 8.3 to 1.5%.